Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound

[1]  R. Nagai,et al.  Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention , 2013, Heart and Vessels.

[2]  M. Hochadel,et al.  Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry , 2012, Heart and Vessels.

[3]  N. Weissman,et al.  In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents. , 2011, The Journal of invasive cardiology.

[4]  M. Kimura,et al.  Difference of Tissue Characteristics Between Early and Very Late Restenosis Lesions After Bare-Metal Stent Implantation: An Optical Coherence Tomography Study , 2011, Circulation. Cardiovascular interventions.

[5]  Masataka Nakano,et al.  The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.

[6]  Seung‐Jung Park,et al.  Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. , 2010, The American journal of cardiology.

[7]  Shaosong Zhang,et al.  Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study , 2010, Heart.

[8]  B. Brott.  Late vascular healing response to stents: new insights from optical coherence tomography. , 2009, Journal of the American College of Cardiology.

[9]  Yoshihiko Seino,et al.  Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. , 2009, Journal of the American College of Cardiology.

[10]  A. Maseri,et al.  Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. , 2009, The American journal of cardiology.

[11]  Renu Virmani,et al.  One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[12]  M. Takano,et al.  Extended Follow-Up by Serial Angioscopic Observation for Bare-Metal Stents in Native Coronary Arteries: From Healing Response to Atherosclerotic Transformation of Neointima , 2009, Circulation. Cardiovascular interventions.

[13]  Yoshiyuki Ishihara,et al.  Tissue Characterization of Coronary Plaques , 2008 .

[14]  T. Aoyama,et al.  Conservative medication follow-up for over 20 years of a patient with ischemic heart disease after diagnosis of chronic total occlusion of the 3 main coronary arteries. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[15]  K. Nishigaki,et al.  Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. , 2008, Ultrasound in medicine & biology.

[16]  Shinichiro Tanaka,et al.  Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent , 2008, Heart and Vessels.

[17]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[18]  H. Fujita,et al.  Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. , 2006, Journal of the American College of Cardiology.

[19]  Michio Nakanishi,et al.  Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; Is its efficacy permanent? , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[20]  M. Takano,et al.  Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. , 2003, Journal of the American College of Cardiology.

[21]  P. Serruys,et al.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[22]  M. Nobuyoshi,et al.  Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries , 2002, Circulation.

[23]  M. Arai,et al.  In Vivo Quantitative Tissue Characterization of Human Coronary Arterial Plaques by Use of Integrated Backscatter Intravascular Ultrasound and Comparison With Angioscopic Findings , 2002, Circulation.

[24]  A. Becker,et al.  Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. , 1998, Circulation.

[25]  T. Tung,et al.  Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting , 2011, Heart and Vessels.

[26]  S. Iliceto,et al.  Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents , 2010, Heart and Vessels.

[27]  A Machraoui,et al.  Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. , 2000, Journal of the American College of Cardiology.